ArticleEuropean journal of medical research2025
Analysis of the clinical value and influencing factors of combined detection of tuberculosis-specific cytokines IFN-γ and IL-2 in the diagnosis of active tuberculosis in children and adolescents.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Combining ADA, IFN-γ, and IL-6 as host biomarkers enhances diagnosis of paucibacillary and extrapulmonary tuberculosis.Communications medicine · 2026Article
- Tuberculosis Skin Test for the Diagnosis of Pediatric Tuberculosis: Comparison with Tuberculin Skin Test and Interferon-Gamma Release Assays.Microorganisms · 2026Review
- Usefulness of the combined IFN-γ and IL-2 release test in distinguishing between pulmonary tuberculosis and non-pulmonary tuberculosis.BMC infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to conduct a combined detection of Mycobacterium tuberculosis (MTB) infection using the tuberculosis (TB)-specific cytokine interferon-γ (IFN-γ) and interleukin-2 (IL-2) release assays in hospitalized children and adolescents with TB, evaluate the clinical value of this technique in the diagnosis of active TB in children and adolescents, and to analyze the related influencing factors.
methodA retrospective study was conducted to collect data from suspected pediatric and adolescent TB patients hospitalized at Chengdu Public Health Clinical Medical Center between April 2022 and December 2024. The combined detection of MTB infection using IFN-γ and IL-2 release assays (referred to as "dual-factor detection of TB infection") was carried out. Microbiological or molecular biological test results of MTB were also obtained. A total of 904 patients diagnosed with TB and 176 non-TB patients were included in the analysis of the effectiveness of dual-factor TB infection testing and related influencing factors.
resultsThe combined detection of IFN-γ and/or IL-2 demonstrated improved diagnostic performance for active tuberculosis (ATB), with a sensitivity of 91.04% and specificity of 65.34% (AUC = 0.782, 95% CI 0.745-0.818). While IFN-γ and IL-2 levels showed no significant differences between MTB-positive and MTB-negative subgroups within the TB cohort (IFN-γ: 365.52 vs. 382.11 pg/ml; IL-2: 241.56 vs. 213.12 pg/ml), both cytokines were markedly elevated in the TB group compared to non-TB controls (IFN-γ: 68.1 pg/ml; IL-2: 41.68 pg/ml). Age-related variations were observed in IFN-γ (P < 0.05) but not IL-2 concentrations. Untreated patients exhibited higher median levels of IFN-γ (397.9 vs. 306.0 pg/ml) and IL-2 (239.2 vs. 173.3 pg/ml) than treated individuals. Among 904 ATB cases, 8.96% (81/904) were false-negative for both cytokines. Multivariate analysis identified advanced age, retreatment TB, pleural effusion, and TST positivity as independent risk factors for dual-negative results (all P < 0.05).
conclusionIn pediatric and adolescent patients, the combined detection of IFN-γ and IL-2 exhibits high sensitivity and specificity in diagnosing ATB. The test is convenient, stable, and highly accurate, making it of great significance for the early diagnosis of TB and the evaluation of treatment effects. Age, a positive TST result, retreatment TB, and the presence of pleural effusion may all influence the results of IFN-γ and/or IL-2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.